TMCnet News

European Robotic Surgery Interventions Reimbursement Report 2017 - Research and Markets

[July 04, 2017]

European Robotic Surgery Interventions Reimbursement Report 2017 - Research and Markets

Research and Markets has announced the addition of the "Robotic Surgery Interventions - European Reimbursement Report" report to their offering.

This report presents summary of reimbursement situation for procedures using robotic equipment in European countries.

The five most common robotic surgical procedures are included in the report:

- Total prostatectomy for prostate cancer

- Total nephrectomy for kidney cancer

- Total hysterectomy for endometrial cancer

- Anterior resection of rectum for rectal cancer

- Nissen (total) fundoplication for gastro-esophageal reflux disease (GERD)

Three types of surgical access are considered in the report:

- Open access

- Laparoscopic access

- Robot-assisted access

Reportincludes essential information about reimbursement and national funding, including:

- Brief overview of reimbursement system for medical devices

- Procedure coding for technology

- Diagnosis coding

- Payment mechanism for technology

- Reimbursement tariffs for technology

- Restrictions in indications or scenarios for use of technology

- Policy considerations by payers and policy-makers about technology

Companies Mentioned

- Auris Surgical Robotics

- Corindus Vascular Robotics (CorPath®)

- Elmed medical systems (Avicenna Roboflex)

- Hansen Medical (Magellan (News - Alert))

- Intuitive Surgical (da Vinci®)

- KB Medical (AQrate)

- Mazor Robotics (Renaissance®)

- Medrobotics (Flex®)

- OR Productivity (FreeHand)

- Renishaw (neuromate®)

- Robocath

- Smith & Nephew (NAVIO)

- Stereotaxis (Epoch®)

- Stryker (Mako platform)

- THINK Surgical (TSolution One®)

- Titan Medical (SPORT)

- TransEnterix (SurgiBot)

- Verb Surgical

- Virtual Incision